| Alternative name | stock no 260 |
|---|---|
| Depositor|Developer | Niwa, Hitoshi | |
| Remarks, protocol and/or map (pdf) | RDB09329p.pdf |
|---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Terms and conditions for distribution | (Cell. Oct 30;95(3):379-391(1998)). Additional terms and conditions: Further transfer, provision of services or resale of the Zeocin resistance gene, and the Deposited Materials is prohibited without InvivoGen's prior written consent. In addition, InvivoGen’s Limited Use Label License applies to your use of this product. |
|---|---|
| Remarks | Zeocin® is a trademark of InvivoGen registered with the United States Patent and Trademark Office and foreign equivalents. See InvivoGen Limited Use Label License. |
[open/close]| MTAに書く使用条件 | (Cell. Oct 30;95(3):379-391(1998))。 付加的使用条件: InvivoGen社の事前の書面による同意がない限り、ゼオシン耐性遺伝子および寄託マテリアルの第三者への移転、サービスの提供、または再販売は禁止されています。また、ご利用に際してInvivoGen社のLimited Use Label Licenseが適用されます。 |
|---|---|
| 備考 | ZeocinはInvivoGen社の製品です。Zeocin®は、米国特許商標庁および米国外の同等機関に登録されたInvivoGen社の商標です。InvivoGen Limited Use Label Licenseをご確認ください。 |
| Catalog # | Resource name | Availability | Shipping form | Fee |
|---|---|---|---|---|
| RDB09329 | pGTIRESzeocinpA | Under QC test. Please contact us. | Please contact us. |
Materials & Methods section:
| The pGTIRESzeocinpA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB09329). |
Reference section:
| Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Scholer, H., Smith, A., Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (3): 379-391 (1998). PMID 9814708. [PubMed] [Article] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Nichols, J., Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (3): 379-391 (1998). PMID 9814708. [PubMed] [Article] |
|---|
Featured content